91 results on '"Yasue, H."'
Search Results
2. East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina.
- Author
-
Mizuno Y, Harada E, Kugimiya F, Shono M, Kusumegi I, Yoshimura M, Kinoshita K, and Yasue H
- Subjects
- Aged, Angina Pectoris ethnology, Angina Pectoris physiopathology, Coronary Vasospasm ethnology, Coronary Vasospasm physiopathology, Female, Humans, Japan epidemiology, Male, Middle Aged, Nitroglycerin adverse effects, Vasoconstriction genetics, Vasodilator Agents adverse effects, Aldehyde Dehydrogenase, Mitochondrial genetics, Angina Pectoris drug therapy, Angina Pectoris genetics, Asian People genetics, Coronary Vasospasm drug therapy, Coronary Vasospasm genetics, Drug Resistance genetics, Nitroglycerin administration & dosage, Polymorphism, Genetic, Vasoconstriction drug effects, Vasodilator Agents administration & dosage
- Abstract
Background: Aldehyde dehydrogenase 2 (ALDH2) plays a central role in the biotransformation of glyceryl trinitrate (GTN) or nitroglycerin, which is widely used for the treatment of coronary artery disease (CAD). The deficient variant ALDH2 genotype (ALDH2*2) is prevalent among East Asians. This study examined whether there are differences in nitroglycerine-mediated dilation (NMD) and flow-mediated dilation (FMD) response between wildALDH2*1/*1and variantALDH2*2patients with CAD.Methods and Results:The study subjects comprised 55 coronary spastic angina (CSA) patients, confirmed by coronary angiography and intracoronary injection of acetylcholine (42 men and 13 women, mean age 68.0±9.0 years). They underwent NMD and FMD tests in the morning before and after continuous transdermal GTN administration for 48 h. NMD was lower at baseline inALDH2*2than in theALDH2*1/*1group (P=0.0499) and decreased significantly in both groups (P<0.0001 and P<0.0001, respectively) after GTN, with significantly lower levels in theALDH2*2group (P=0.0002). FMD decreased significantly in bothALDH2*1/*1andALDH2*2groups (P<0.0001and P=0.0002, respectively) after continuous GTN administration, with no significant differences between the 2 groups both before and after GTN., Conclusions: Continuous administration of GTN produced endothelial dysfunction as well as nitrate tolerance in bothALDH2*1/1andALDH2*2patients with CSA.ALDH2*2attenuated GTN response and exacerbated GTN tolerance, but not endothelial dysfunction, as compared toALDH2*1/*1in patients with CSA.
- Published
- 2020
- Full Text
- View/download PDF
3. Coronary artery spasm - Clinical features, pathogenesis and treatment.
- Author
-
Yasue H, Mizuno Y, and Harada E
- Subjects
- Animals, Coronary Vasospasm diagnosis, Coronary Vasospasm metabolism, Electrocardiography, Humans, Coronary Vasospasm etiology, Coronary Vasospasm therapy
- Abstract
Coronary artery spasm (CAS) plays an important role in the pathogenesis of ischemic heart disease, including angina pectoris, myocardial infarction, and sudden death, occurring most often from midnight to early morning. CAS is prevalent among East Asians and is associated with an aldehyde dehydrogenase 2 (ALDH2)-deficient genotype (ALDH2*2) and alcohol flushing, which is prevalent among East Asians but is virtually non-existent in other populations. ALDH2 eliminates not only acetaldehyde but also other toxic aldehydes from lipid peroxidation and tobacco smoking, thereby protecting tissues and cells from oxidative damage. Risk factors for CAS include smoking and genetic polymorphisms including those of ALDH2*2, endothelial NO synthase, paraoxonase I, and interleukin-6. Accordingly, oxidative stress, endothelial dysfunction, and low-grade chronic inflammation play an important role in the pathogenesis of CAS, leading to increased coronary smooth muscle Ca
2+ sensitivity through RhoA/ROCK activation and resultant hypercontraction. Ca-channel blockers blocking the intracellular entry of Ca2+ are specifically effective for treatment for CAS.- Published
- 2019
- Full Text
- View/download PDF
4. Association of East Asian Variant Aldehyde Dehydrogenase 2 Genotype (ALDH2*2*) with Coronary Spasm and Acute Myocardial Infarction.
- Author
-
Yasue H, Mizuno Y, and Harada E
- Subjects
- Asian People, Genotype, Humans, Aldehyde Dehydrogenase, Mitochondrial genetics, Coronary Vasospasm genetics, Myocardial Infarction genetics
- Abstract
Coronary spasm plays an important role in the pathogenesis of ischemic heart disease, including angina pectoris, acute myocardial infarction (AMI), silent myocardial ischemia, and sudden death. The prevalence of coronary spasm is higher among East Asians probably due to genetic as well as environmental factors. ALDH2 eliminates toxic aldehydes including 4-hydroxy-2-nonenal (4-HNE) derived from lipid peroxidation and acrolein in tobacco smoking as well as ethanol-derived acetaldehyde and thereby protects tissues and cells from oxidative damage. Deficient variant ALDH2*2 genotype is prevalent among East Asians and is a significant risk factor for both coronary spasm and AMI through accumulation of toxic aldehydes, thereby contributing to oxidative stress, endothelial damage, vasoconstriction, and thrombosis. Toxic aldehydes are thus identified as risk factors to be targeted for the treatment of coronary spasm and AMI.
- Published
- 2019
- Full Text
- View/download PDF
5. Variant Aldehyde Dehydrogenase 2 (ALDH2*2) in East Asians Interactively Exacerbates Tobacco Smoking Risk for Coronary Spasm - Possible Role of Reactive Aldehydes.
- Author
-
Mizuno Y, Hokimoto S, Harada E, Kinoshita K, Yoshimura M, and Yasue H
- Subjects
- Aged, Aldehyde Dehydrogenase, Mitochondrial metabolism, Asian People, Cholesterol, HDL blood, Female, Humans, Japan, Male, Middle Aged, Sex Factors, Uric Acid blood, Aldehyde Dehydrogenase, Mitochondrial genetics, Aldehydes blood, Angina Pectoris blood, Angina Pectoris enzymology, Angina Pectoris etiology, Angina Pectoris genetics, Coronary Vasospasm blood, Coronary Vasospasm enzymology, Coronary Vasospasm etiology, Coronary Vasospasm genetics, Genotype, Smoking adverse effects, Smoking blood, Smoking genetics
- Abstract
Background: Coronary spastic angina (CSA) is common among East Asians and tobacco smoking (TS) is an established risk factor for CSA. Aldehyde dehydrogenase 2 (ALDH2) plays a key role in removing reactive toxic aldehydes and a deficient variant ALDH2 genotype (ALDH2*2) is prevalent among East Asians. We examined the interaction between TS andALDH2*2as a risk factor for CSA to better understand the disease pathogenesis.Methods and Results:The study subjects comprised 410 patients (258 men, 152 women; mean age, 66.3±11.5) in whom intracoronary injection of acetylcholine was performed on suspicion of CSA.ALDH2genotyping was performed by direct application of the Taqman polymerase chain reaction system. Of the study subjects, 244 had CSA proven and 166 were non-CSA. The frequencies of male sex,ALDH2*2, alcohol flushing syndrome, TS, coronary organic stenosis, and plasma levels of uric acid were higher (P<0.001, P<0.001, P<0.001, P<0.001, P<0.001, and P=0.015, respectively) and that of high-density lipoprotein cholesterol lower (P=0.002) in the CSA than non-CSA group. Multivariable logistic regression analysis revealed thatALDH2*2and TS were significant risk factors for CSA (P<0.001 and P=0.002, respectively).ALDH2*2exacerbated TS risk for CSA more than the multiplicative effects of each., Conclusions: ALDH2*2synergistically exacerbates TS risk for CSA, probably through aldehydes.
- Published
- 2016
- Full Text
- View/download PDF
6. [Coronary spasm and its underlying mechanisms].
- Author
-
Yasue H, Mizuno Y, and Harada E
- Subjects
- Animals, Endothelium, Vascular metabolism, Endothelium, Vascular physiopathology, Humans, Mice, Muscle, Smooth, Vascular physiopathology, Nitric Oxide metabolism, Coronary Vasospasm physiopathology
- Published
- 2016
7. Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST-Segment Elevation Myocardial Infarction.
- Author
-
Mizuno Y, Hokimoto S, Harada E, Kinoshita K, Nakagawa K, Yoshimura M, Ogawa H, and Yasue H
- Subjects
- Aged, Asian People, Central Nervous System Depressants adverse effects, Creatine Kinase blood, Ethanol adverse effects, Female, Flushing chemically induced, Flushing genetics, Genetic Predisposition to Disease, Genetic Variation, Genotype, Humans, Japan, Male, Middle Aged, Percutaneous Coronary Intervention, Risk Factors, ST Elevation Myocardial Infarction blood, ST Elevation Myocardial Infarction surgery, Severity of Illness Index, Troponin T blood, Aldehyde Dehydrogenase, Mitochondrial genetics, Coronary Vasospasm genetics, ST Elevation Myocardial Infarction genetics
- Abstract
Background: Mitochondrial aldehyde dehydrogenase 2 (ALDH2) plays a key role in removing toxic aldehydes. Deficient variant ALDH2*2 genotype is prevalent in up to 40% of the East Asians and reported to be associated with acute myocardial infarction (AMI). To elucidate the mechanisms underlying the association of ALDH2*2 with AMI, we compared the clinical features of AMI patients with ALDH2*2 to those with wild-type ALDH2*1/*1., Methods and Results: The study subjects consisted of 202 Japanese patients with acute ST-segment elevation myocardial infarction (STEMI) (156 men and 46 women; mean age, 67.3±12.0) who underwent primary percutaneous coronary intervention (PCI). In 85 patients, provocation test for coronary spasm was also done 6 month post-PCI. ALDH2 genotyping was performed by direct application of the TaqMan polymerase chain system. Of the 202 patients, 103 (51.0%) were carriers of ALDH2*2 and 99 (49.0%) those of ALDH2*1/*1. There were no differences in clinical features between ALDH2*2 and ALDH2*1/*1 carrier groups except higher frequencies of coronary spasm and alcohol flush syndrome (AFS) (88.6% vs 56.1%; P=0.001 and 94.3% vs 17.6%; P<0.001), less-frequent alcohol habit (14.6% vs 51.5%; P<0.001), and higher peak plasma creatine phophokinase levels (2224 vs 1617 mg/dL; P=0.002) in the ALDH2*2 than the ALDH2*1/*1 carrier group., Conclusions: ALDH2*2 is prevalent (51.0%) among Japanese STEMI patients, and those with ALDH2*2 had higher frequencies of coronary spasm and AFS and more-severe myocardial injury compared to those with ALDH2*1/*1., (© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.)
- Published
- 2016
- Full Text
- View/download PDF
8. Response to Letter Regarding Article, "East Asian Variant of Aldehyde Dehydrogenase 2 Is Associated With Coronary Spastic Angina: Possible Roles of Reactive Aldehydes and Implications of Alcohol Flushing Syndrome".
- Author
-
Mizuno Y, Harada E, Morita S, Kinoshita K, Hayashida M, Shono M, Morikawa Y, Murohara T, Nakayama M, Yoshimura M, and Yasue H
- Subjects
- Female, Humans, Male, Aldehyde Dehydrogenase deficiency, Aldehydes metabolism, Coronary Vasospasm genetics, Ethanol adverse effects, Flushing chemically induced
- Published
- 2015
- Full Text
- View/download PDF
9. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome.
- Author
-
Mizuno Y, Harada E, Morita S, Kinoshita K, Hayashida M, Shono M, Morikawa Y, Murohara T, Nakayama M, Yoshimura M, and Yasue H
- Subjects
- Acetylcholine, Aged, Aldehyde Dehydrogenase genetics, Aldehyde Dehydrogenase, Mitochondrial, Cholesterol, HDL blood, Coronary Angiography, Coronary Vasospasm diagnostic imaging, Coronary Vasospasm enzymology, Coronary Vasospasm ethnology, Coronary Vessels, Female, Genotype, Humans, Injections, Intra-Arterial, Japan, Lipid Peroxidation, Male, Middle Aged, Oxidative Stress, Polymorphism, Single Nucleotide, Risk Factors, Smoking epidemiology, Uric Acid blood, Aldehyde Dehydrogenase deficiency, Aldehydes metabolism, Coronary Vasospasm genetics, Ethanol adverse effects, Flushing chemically induced
- Abstract
Background: Coronary spastic angina (CSA) is a common disease among East Asians, including Japanese. The prevalence of alcohol flushing syndrome associated with deficient activity of the variant aldehyde dehydrogenase 2 (ALDH2*2) genotype is prevalent among East Asians. We examined whether CSA is associated with the ALDH2*2 genotype in Japanese., Methods and Results: The study subjects consisted of 202 patients in whom intracoronary injection of acetylcholine was performed by angiography on suspicion of CSA (119 men and 83 women; mean age, 66.2±11.4 years). They were divided into CSA (112 patients) and control groups (90 patients). ALDH2 genotyping was performed by the direct application of the TaqMan polymerase chain reaction system on dried whole blood. Clinical and laboratory data were examined using conventional methods. The frequencies of male sex, ALDH2*2 genotype carriers, alcohol flushing syndrome, tobacco smoking, and the plasma level of uric acid were higher (P<0.001, P<0.001, P<0.001, P<0.001, and P=0.007, respectively) and the plasma high-density lipoprotein cholesterol levels were lower (P<0.001) in the CSA group than in the control group. The multivariable logistic regression analysis revealed that ALDH2*2 genotype and smoking were significantly associated with CSA (P<0.001 and P=0.024, respectively)., Conclusions: East Asian variant ALDH2*2 genotypes and, hence, deficient ALDH2 activity were associated with CSA in Japanese. These data support further investigation of treatment targeting aldehydes for CSA., (© 2015 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
10. High incidence of coronary spasm after percutaneous coronary interventions: comparison between new generation drug-eluting stent and bare-metal stent.
- Author
-
Hokimoto S, Mizuno Y, Sueta D, Morita S, Akasaka T, Tabata N, Harada E, Arima Y, Yamamuro M, Tanaka T, Yamamoto E, Sakamoto K, Tsujita K, Kaikita K, Yasue H, and Ogawa H
- Subjects
- Aged, Coronary Vasospasm diagnosis, Coronary Vasospasm etiology, Female, Humans, Incidence, Japan epidemiology, Male, Postoperative Complications etiology, Prosthesis Design, Retrospective Studies, Coronary Vasospasm epidemiology, Drug-Eluting Stents, Myocardial Infarction surgery, Percutaneous Coronary Intervention adverse effects, Postoperative Complications epidemiology
- Published
- 2015
- Full Text
- View/download PDF
11. Letter by Yasue et al regarding article, "Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries".
- Author
-
Yasue H, Mizuno Y, and Harada E
- Subjects
- Female, Humans, Male, Acetylcholine, Coronary Angiography, Coronary Vasospasm diagnosis, Coronary Vessels drug effects, Myocardial Ischemia diagnosis
- Published
- 2015
- Full Text
- View/download PDF
12. Pioglitazone, a peroxisome proliferator-activated receptor γ activator, suppresses coronary spasm.
- Author
-
Morita S, Mizuno Y, Harada E, Kashiwagi Y, Yoshimura M, Murohara T, and Yasue H
- Subjects
- Acetylcholine, Aged, Angina Pectoris diagnosis, Angina Pectoris physiopathology, Calcium Channel Blockers therapeutic use, Coronary Angiography, Coronary Vasospasm diagnosis, Coronary Vasospasm physiopathology, Coronary Vessels metabolism, Coronary Vessels physiopathology, Drug Therapy, Combination, Female, Humans, Japan, Male, Middle Aged, PPAR gamma metabolism, Pilot Projects, Pioglitazone, Time Factors, Treatment Outcome, Angina Pectoris prevention & control, Coronary Vasospasm prevention & control, Coronary Vessels drug effects, PPAR gamma agonists, Thiazolidinediones therapeutic use, Vasodilator Agents therapeutic use
- Abstract
Objective: We examined whether a peroxisome proliferator-activated receptor γ (PPAR-γ) agonist, pioglitazone, suppresses coronary spasm., Background: Patients with coronary spastic angina (CSA) also have endothelial dysfunction and inflammation. Activation of PPAR-γ improves endothelial dysfunction and inflammation., Participants and Methods: The study participants included 73 consecutive CSA patients (47 men and 26 women, mean age 63.6±10.4 years) who were admitted to our institution with a suspicion of CSA because of episodes of chest discomfort occurring mostly at rest in whom coronary spasm was induced by an intracoronary acetylcholine injection and a repeat acetylcholine provocation injection was administered after 6 months of follow-up. Thirty-six of the patients were administered pioglitazone15-30 mg/day added on calcium channel blockers (CCBs) (pioglitazone group) and 37 were administered CCBs alone (control group). Clinical and laboratory data were also examined before and after 6 months of follow-up and the results between the two groups were compared., Results: Coronary spasm was suppressed in 18/36 patients (50.0%) in the pioglitazone group (P<0.001) and 8/37 patients (21.6%) in the control group (P=0.008) after 6 months of treatment. Coronary spasm was thus significantly reduced in the pioglitazone group compared with the control group (P=0.011). The levels of total white blood cell count and high-sensitivity C-reactive protein decreased significantly (P<0.001 and P<0.001, respectively) in the pioglitazone group, whereas these levels did not differ in the control group (P=0.15 and 0.39, respectively) after the treatment., Conclusion: Pioglitazone added on CCBs significantly reduced coronary spasm compared with CCBs alone after 6 months of treatment. Pioglitazone may thus prove to be a novel therapy for coronary spasm.
- Published
- 2014
- Full Text
- View/download PDF
13. Differences and interactions between risk factors for coronary spasm and atherosclerosis--smoking, aging, inflammation, and blood pressure.
- Author
-
Morita S, Mizuno Y, Harada E, Nakagawa H, Morikawa Y, Saito Y, Katoh D, Kashiwagi Y, Yoshimura M, Murohara T, and Yasue H
- Subjects
- Aged, Anti-Arrhythmia Agents therapeutic use, Atherosclerosis blood, Atherosclerosis complications, Atherosclerosis etiology, Body Mass Index, C-Reactive Protein metabolism, Calcium Channel Blockers therapeutic use, Chest Pain blood, Chest Pain etiology, Coronary Vasospasm blood, Coronary Vasospasm etiology, Cross-Sectional Studies, Female, Humans, Inflammation blood, Inflammation complications, Japan, Lipids blood, Male, Predictive Value of Tests, Risk Factors, Smoking physiopathology, Aging, Atherosclerosis physiopathology, Blood Pressure, Chest Pain physiopathology, Coronary Vasospasm physiopathology, Inflammation physiopathology, Smoking adverse effects
- Abstract
Objective Coronary spasm as well as atherosclerosis plays an important role in the pathogenesis of coronary heart disease. However, the relationship between coronary spasm and atherosclerosis is not well known. The purpose of the present study was to examine the differences and interactions between risk factors for coronary spasm and atherosclerosis and thereby explore the pathogenesis of coronary spasm. Methods The study subjects consisted of 938 patients with chest discomfort (522 men and 416 women, mean age 65.2±11.0) who underwent intracoronary-acetylcholine provocation tests for coronary spasm. Coronary risk factors, including age, gender, body mass index, blood pressure, high-sensitivity C-reactive protein (hsCRP), white blood cells, glucose, lipid profiles, and other laboratory chemistries were examined. Results Four hundred and ninety-six patients (315 men and 181 women, mean age: 65.1±11.4) were diagnosed with coronary spastic angina (CSA), while the remaining 442 patients (207 men and 235 women, mean age: 65.3±10.7) were diagnosed with non-CSA. A multiple logistic regression analysis revealed men, smoking, hsCRP, and low diastolic blood pressure (DBP) to be predictors (p=0.001, p=0.009, p=0.034, and p=0.041, respectively) for CSA, while age, diabetes mellitus, low high-density lipoprotein-cholesterol, systolic blood pressure (SBP), uric acid and male gender were found to be predictors (p<0.001, p<0.001, p<0.001, p=0.002, p=0.006 and p=0.029, respectively) for atherosclerosis. Conclusion Predictors for coronary spasm were smoking, hsCRP and low DBP, whereas those for atherosclerosis were age, diabetes mellitus, high SBP, and uric acid in that order. These findings suggest that the pathogenesis of coronary spasm differs from that of atherosclerosis.
- Published
- 2014
- Full Text
- View/download PDF
14. Coronary spastic angina is associated with insulin resistance - possible involvement of endothelial dysfunction.
- Author
-
Kashiwagi Y, Harada E, Mizuno Y, Morita S, Shono M, Murohara T, Yoshimura M, and Yasue H
- Subjects
- Aged, Angina Pectoris blood, Angina Pectoris diagnosis, Angina Pectoris epidemiology, Biomarkers blood, Blood Glucose metabolism, Case-Control Studies, Cholesterol, HDL blood, Coronary Angiography, Coronary Vasospasm blood, Coronary Vasospasm diagnosis, Coronary Vasospasm epidemiology, Coronary Vessels metabolism, Cross-Sectional Studies, Endothelium, Vascular metabolism, Female, Glucose Intolerance blood, Glucose Intolerance diagnosis, Glucose Intolerance epidemiology, Glucose Tolerance Test, Humans, Insulin blood, Japan epidemiology, Male, Middle Aged, Risk Factors, Smoking adverse effects, Angina Pectoris physiopathology, Coronary Vasospasm physiopathology, Coronary Vessels physiopathology, Endothelium, Vascular physiopathology, Glucose Intolerance physiopathology, Insulin Resistance
- Abstract
Objective: In this study, we examined whether coronary spastic angina (CSA) is associated with insulin resistance., Background: There is increasing evidence that insulin resistance is associated with endothelial dysfunction. Patients with CSA show endothelial dysfunction., Methods: The study participants include 111 CSA patients (81 men and 30 women, mean age 62±12 years) and 53 participants without CSA (24 men and 29 women, mean age 63±10 years), serving as the controls. The oral glucose tolerance test was performed, and anthropometric parameters, plasma glucose and insulin levels, lipid profiles, and other laboratory parameters were evaluated., Results: Homeostasis model assessment of insulin resistance (HOMA-IR), Log HOMA-IR, the quantitative insulin sensitivity check index, the insulin sensitivity index, and insulin resistance 60-120 min after glucose load (log post-glucose-IR) were calculated as surrogate markers of insulin resistance. The number of men, the number of smokers, log post-glucose-IR, the insulin sensitivity index, and fasting plasma glucose levels were higher in CSA patients compared with controls (P=0.001, 0.001, 0.004, 0.012, and 0.013, respectively), whereas plasma high-density lipoprotein cholesterol levels were lower (P<0.001)., Conclusion: Insulin resistance on glucose load (log post-glucose-IR), plasma high-density lipoprotein cholesterol levels, and smoking were significantly associated with CSA (r=0.225, P=0.004; r=-0.313, P<0.001; and r=0.258, P=0.001, respectively).
- Published
- 2013
- Full Text
- View/download PDF
15. Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improvement in endothelial function, oxidative stress, and inflammation.
- Author
-
Morikawa Y, Mizuno Y, Harada E, Katoh D, Kashiwagi Y, Morita S, Yoshimura M, Uemura S, Saito Y, and Yasue H
- Subjects
- Aged, Angina Pectoris blood, Angina Pectoris diagnosis, Angina Pectoris physiopathology, Biomarkers blood, C-Reactive Protein metabolism, Circadian Rhythm, Coronary Angiography, Coronary Artery Disease blood, Coronary Artery Disease diagnosis, Coronary Artery Disease physiopathology, Coronary Vasospasm blood, Coronary Vasospasm diagnosis, Coronary Vasospasm physiopathology, Female, Humans, Inflammation blood, Inflammation diagnosis, Inflammation physiopathology, Inflammation Mediators blood, Insulin Resistance, Interleukin-6 blood, Male, Middle Aged, Pilot Projects, Reactive Oxygen Species blood, Time Factors, Treatment Outcome, Angina Pectoris prevention & control, Coronary Artery Disease therapy, Coronary Vasospasm prevention & control, Endothelium, Vascular physiopathology, Exercise Therapy, Inflammation prevention & control, Oxidative Stress, Vasodilation
- Abstract
Background: Coronary spasm plays an important role in the pathogenesis of ischemic heart disease. Endothelial function is impaired in patients with coronary spasm. Exercise training has been shown to improve endothelial function., Objective: We examined the effects of aerobic interval exercise training (AIT) on attacks in conjunction with endothelial function in patients with coronary spastic angina., Participants and Methods: The study participants were 26 patients with rest angina (19 men and 7 women, mean age 61.7±11.7 years) in whom coronary spasm was documented and no severe organic lesions were found. The numbers of attacks and of individuals with attacks were examined in conjunction with endothelial function, oxidative stress, inflammation, and insulin resistance before and after 3 successive days of AIT., Results: The number of attacks/patient and the ratio of patients with attacks/5 days decreased [from 2 (1, 7) to 0 (0, 2), P<0.001, and from 23/26 (88.5%) to 10/26 (38.5%), P<0.001] in conjunction with the improvement in endothelial function assessed by improved flow-mediated dilatation (4.8±2.7 vs. 6.9±2.8%, P<0.001), plasma levels of diacron-reactive oxygen metabolites (363±58 vs. 349±61 U.CARR, P=0.001), interleukin-6[1.63 (1.33, 2.22) vs. 1.39 (1.09, 2.02) pg/ml, P=0.012], high-sensitivity C-reactive protein [0.087 (0.041, 0.136) vs. 0.063 (0.028, 0.085) mg/dl, P=0.028], and homeostasis model assessment-insulin resistance [1.79 (1.41, 2.39) vs. 1.54 (1.17, 1.79) mg/dl µU/ml, P=0.005] after AIT., Conclusion: AIT in the afternoon suppressed the attacks in conjunction with improvement in endothelial function, oxidative stress, inflammation, and insulin resistance in patients with coronary spastic angina.
- Published
- 2013
- Full Text
- View/download PDF
16. Alcohol flushing and positive ethanol patch test in patients with coronary spastic angina: possible role of aldehyde dehydrogenase 2 polymorphisms.
- Author
-
Mizuno Y, Morita S, Harada E, Shono M, Morikawa Y, Murohara T, and Yasue H
- Subjects
- Aged, Aldehyde Dehydrogenase, Mitochondrial, Angina Pectoris enzymology, Angina Pectoris genetics, Asian People genetics, Case-Control Studies, Coronary Vasospasm enzymology, Coronary Vasospasm genetics, Ethanol adverse effects, Female, Flushing enzymology, Flushing genetics, Humans, Japan, Male, Middle Aged, Patch Tests, Polymorphism, Genetic, Risk Factors, Alcohol Drinking adverse effects, Aldehyde Dehydrogenase genetics, Angina Pectoris etiology, Coronary Vasospasm etiology, Flushing etiology
- Abstract
Objective: Coronary spasm plays an important role in the pathogenesis of coronary heart disease (CHD) and angina pectoris caused by coronary spasm or coronary spastic angina (CSA) is prevalent in Japan. However, the precise mechanisms underlying coronary spasm are unclear. Alcohol intolerance is prevalent among East Asians, and we previously reported that coronary spasm could be induced by alcohol intake in CSA patients. We herein examined whether CSA is associated with alcohol intolerance in Japanese subjects., Methods: The study subjects consisted of 80 CSA patients (57 men/ 23 women, mean age 62 ± 12) and 52 non-CSA patients (25 men/27 women, mean age 63 ± 10). The ethanol patch test (EPT) and questionnaire which evaluates flushing after ethanol intake, along with an examination of clinical features and laboratory chemistry data for CHD risk factors were done. Gender (male) and smoking were higher (p=0.007, and p=0.019, respectively) and plasma HDL cholesterol level was lower (p=0.035) in the CSA patients than in the non-CSA patients. Multivariable logistic regression analysis including age, EPT, smoking, and plasma HDL cholesterol level as independent variables revealed that positive EPT and smoking were significant predictors of CSA (p=0.011 and p=0.016, respectively)., Conclusion: Positive EPT and alcohol flushing following alcohol intake, as well as smoking and plasma levels of HDL cholesterol, were significantly associated with CSA in Japanese patients. Therefore, alcohol ingestion as well as smoking is a significant risk factor for CSA in Japanese.
- Published
- 2013
- Full Text
- View/download PDF
17. High incidence of provoked coronary spasm in the presence of a stent after myocardial infarction: therapeutic and prognostic implications.
- Author
-
Katoh D, Mizuno Y, Harada E, Ito T, Morikawa Y, Nakagawa H, Saito Y, Yoshimura M, and Yasue H
- Subjects
- Aged, Angioplasty, Balloon, Coronary, Calcium Channel Blockers therapeutic use, Case-Control Studies, Coronary Vasospasm drug therapy, Coronary Vasospasm pathology, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prognosis, Coronary Vasospasm epidemiology, Myocardial Infarction therapy, Postoperative Complications, Stents
- Abstract
Objectives: Coronary spasm is implicated in the pathogenesis of acute coronary syndromes including acute myocardial infarction (AMI). Stent implantation in the primary percutaneous coronary intervention is the first choice of treatment for patients with AMI. However, the relationship between coronary spasm and stent implantation after AMI and its clinical implications remain unknown. We examined the incidence and clinical implications of provoked coronary spasm after stent implantation in patients with AMI., Methods: Fifty-seven patients (43 men and 14 women with a mean age of 65.1±12.5 years) with ST elevation AMI who had undergone a stent implantation were the participants of this study. They underwent a provocation test for coronary spasm by intracoronary injection of acetylcholine 2-5 weeks after the attack. The patients with provoked spasms were given calcium channel blockers, and all the participants of the study were followed up for an average of 35.0±26.9 months., Results: Coronary spasm was induced in 40 (70.2%) and multivessel spasm in 17 (29.8%) of the 57 patients. Spasms occurred in 31 (55.4%) of the infarct-related arteries (IRAs) and 33 (30.6%) of the non-IRAs. There was no significant difference (χ=1.01, P=0.314) in the major cardiac events between the spasm group and nonspasm group during the follow-up., Conclusion: Coronary spasm was provoked with a high frequency in both the IRAs and non-IRAs after stent implantation in patients with AMI. Calcium channel blockers may be useful to improve the prognosis in patients with AMI after stent implantation by suppressing coronary spasm.
- Published
- 2012
- Full Text
- View/download PDF
18. Letter by Yasue et al regarding article, "Mechanisms of coronary artery spasm".
- Author
-
Yasue H, Yoshimura M, and Saito Y
- Subjects
- Humans, Coronary Vasospasm etiology
- Published
- 2012
- Full Text
- View/download PDF
19. Nitrate tolerance as a possible cause of multidrug-resistant coronary artery spasm.
- Author
-
Morikawa Y, Mizuno Y, Harada E, Kuboyama O, Yoshimura M, and Yasue H
- Subjects
- Adult, Calcium Channel Blockers adverse effects, Coronary Vasospasm therapy, Drug Resistance, Multiple, Humans, Male, Nitroglycerin adverse effects, Vasodilator Agents adverse effects, Coronary Vasospasm chemically induced, Coronary Vasospasm diagnosis, Drug Tolerance physiology, Nitrates adverse effects
- Abstract
Coronary spasm can usually be controlled by administration of Ca antagonists. However, there are some cases of coronary spasm whose attacks cannot be controlled even with large doses of Ca antagonist and/or its combination with nitrates. Here we describe the case of a 41-year-old man whose attacks of coronary spasm were resistant to the combined administration of nitrates, Ca antagonists, and a statin. The attacks were alleviated and disappeared after withdrawal of nitrates and recurred after readministration of a nitroglycerin patch. The involvement of nitrate tolerance in the pathogenesis of multidrug resistant coronary spasm was revealed and its implication discussed.
- Published
- 2010
- Full Text
- View/download PDF
20. Letter by Morikawa et al regarding article, "coronary artery spasm: a 2009 update".
- Author
-
Morikawa Y, Mizuno Y, and Yasue H
- Subjects
- Humans, Calcium Channels therapeutic use, Coronary Vasospasm diagnosis, Coronary Vasospasm drug therapy, Coronary Vasospasm etiology
- Published
- 2010
- Full Text
- View/download PDF
21. Coronary spasm preferentially occurs at branch points: an angiographic comparison with atherosclerotic plaque.
- Author
-
Nakagawa H, Morikawa Y, Mizuno Y, Harada E, Ito T, Matsui K, Saito Y, and Yasue H
- Subjects
- Acetylcholine, Adult, Aged, Aged, 80 and over, Coronary Artery Disease physiopathology, Coronary Vasospasm physiopathology, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Vasoconstrictor Agents, Coronary Angiography, Coronary Artery Disease diagnostic imaging, Coronary Vasospasm diagnostic imaging, Vasoconstriction
- Abstract
Background: Coronary spasm plays an important role in the pathogenesis of ischemic heart disease. However, similarities and differences between coronary spasm and atherosclerosis are not known. We examined the angiographic characteristics of coronary spasm in comparison with those of atherosclerosis., Methods and Results: Thirty-two left anterior descending arteries, 11 left circumflex arteries, and 23 right coronary arteries with spasm and atherosclerotic plaque were analyzed for the localization of spasm in comparison with that of plaque in 47 patients (38 men and 9 women, mean age 66.8+/-10.3 yrs). Spasm predominantly occurred at the branch point as compared with plaque in each of the 3 arteries (76.7% versus 23.3%, P<0.0001; 72.7% versus 9.1%, P<0.039; and 60.0% versus 10.0%, P=0.002, in the left anterior descending, left circumflex, and right coronary arteries, respectively). Spasm involved the proximal segment less frequently as compared with plaque in each of the 3 arteries (56.7% versus 93.3%, P<0.0001; 18.2% versus 81.8%, P=0.016; and 15.0% versus 75.0%, P<0.0001 in the left anterior descending, left circumflex, and right coronary arteries, respectively). Most spasms occurred at the nonplaque site in each of the 3 arteries (73.3%, P=0.018; 100%, P<0.0001; and 75.0%, P=0.041 in the left anterior descending, left circumflex, and right coronary arteries, respectively)., Conclusions: Coronary spasm preferentially occurred at branch points and nonplaque sites, whereas the atherosclerotic lesion was predominantly localized at the nonbranch points of the curved proximal segments. Coronary spasm may thus be a manifestation of a distinct type of arteriosclerosis different from the lipid-laden coronary atherosclerosis.
- Published
- 2009
- Full Text
- View/download PDF
22. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
- Author
-
Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, and Saito Y
- Subjects
- Acetylcholine pharmacology, Adult, Aged, Aged, 80 and over, Coronary Angiography, Coronary Vasospasm physiopathology, Coronary Vessels drug effects, Coronary Vessels pathology, Endothelium physiopathology, Female, Fluvastatin, Humans, Male, Middle Aged, Nitric Oxide, Prospective Studies, Risk Factors, Treatment Outcome, Calcium Channel Blockers therapeutic use, Coronary Vasospasm drug therapy, Endothelium drug effects, Fatty Acids, Monounsaturated therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Indoles therapeutic use
- Abstract
Objectives: The purpose of this study was to determine whether a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) suppresses coronary spasm., Background: Coronary spasm is associated with endothelial dysfunction. Statins have been shown to improve endothelial function., Methods: This was a prospective, randomized, open-label, end point study. Sixty-four patients who had no significant organic coronary stenosis and in whom coronary spasm was induced by intracoronary injection of acetylcholine (ACh) were randomly assigned to fluvastatin 30 mg/day plus the conventional calcium-channel blocker (CCB) therapy (31 patients, statin group) or the conventional CCB therapy (33 patients, nonstatin group). After 6 months of treatment, the intracoronary injection of ACh was repeated and the coronary spasm was assessed., Results: Coronary spasm was suppressed in 16 of the 31 patients (51.5%, p < 0.0001) of the statin group and in 7 of the 33 patients (21.2%, p = 0.0110) of the nonstatin group after 6 months of treatment. Thus, the number of patients with ACh-induced coronary spasm was significantly reduced in the statin group as compared with the nonstatin group (51.6% vs. 21.2%, p = 0.0231) after 6 months of treatment., Conclusions: The addition of fluvastatin 30 mg/day to the conventional CCB therapy for 6 months significantly reduced the number of patients with ACh-induced coronary spasm as compared with the conventional CCB therapy. Thus, a statin (fluvastatin) may possibly be a novel therapeutic drug for coronary spasm.
- Published
- 2008
- Full Text
- View/download PDF
23. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment.
- Author
-
Yasue H, Nakagawa H, Itoh T, Harada E, and Mizuno Y
- Subjects
- Coronary Angiography, Electrocardiography, Humans, Risk Factors, Coronary Vasospasm diagnosis, Coronary Vasospasm etiology, Coronary Vasospasm therapy
- Abstract
Coronary (artery) spasm plays an important role in the pathogenesis of ischemic heart disease, including stable angina, unstable angina, myocardial infarction, and sudden death. The prevalence of coronary spasm differs among populations, is higher in Japan and Korea than in the Western countries probably due to genetic as well as environmental factors. Coronary spasm occurs most often from midnight to early morning and is usually not induced by exercise in the daytime. The attacks of coronary spasm are associated with either ST segment elevation or depression, or negative U wave on ECG. Patients with multi-vessel coronary spasm may suffer from lethal arrhythmia, including advanced AV block, ventricular tachycardia or fibrillation, or even sudden death, and they are often resistant to conventional medical therapy including Ca-channel blockers (CCBs). Endothelial nitric oxide (NO) activity is reduced and markers of oxidative stress are elevated in patients with coronary spasm. Thrombogenesis is enhanced and plasma levels of hsCRP and P-selection are elevated in patients with coronary spasm. Thus, patients with coronary spasm have endothelial dysfunction and are suffering from a low-grade chronic inflammation. Polymorphisms of endothelial NO synthase, smoking, and low-grade inflammation are the most important risk factors for coronary spasm. Coronary spasm is a hyper-contraction of coronary smooth muscle triggered by an increase of intracellular Ca2+ in the presence of an increased Ca2+ sensitivity. It has been shown that RhoA/ROCK pathway is involved in Ca2+ sensitivity and that the reduced endothelial NO activity results in increased Ca2+ sensitivity through enhanced RhoA/ROCK pathway. Accordingly, it is possible that in addition to CCBs, RhoA/ROCK pathway blockers may prove to be useful for the treatment of coronary spasm.
- Published
- 2008
- Full Text
- View/download PDF
24. A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis.
- Author
-
Suzuki S, Yoshimura M, Nakayama M, Abe K, Yamamuro M, Nagayoshi Y, Kojima S, Kaikita K, Sugiyama S, Yasue H, and Ogawa H
- Subjects
- Case-Control Studies, Chromosome Mapping, Female, Genetic Predisposition to Disease, Genome, Human, Haplotypes genetics, Humans, Male, Middle Aged, Coronary Artery Disease genetics, Coronary Vasospasm genetics, Genetic Markers genetics, Polymorphism, Single Nucleotide genetics
- Abstract
Objective: Coronary spasm plays an important role in the pathogenesis of variant angina and also ischemic heart diseases in general, and it is more likely to occur in angiographically normal coronary arteries than in stenotic coronary arteries. We previously found a -786T/C polymorphism in the 5'-flanking region of the endothelial nitric oxide synthase (eNOS) gene and reported that this polymorphism is associated with coronary spasm. We report on an investigation of the genetic factor(s) associated with coronary spasm utilizing a genome-wide case-control study., Methods and Results: We recruited 411 consecutive Japanese women (201 with coronary spasm; 210 controls) who were all underwent an acetylcholine provocation test. For single nucleotide polymorphism analysis (SNP), 116,204 SNPs were genotyped for 100 women (50 with coronary spasm; 50 controls) utilizing the Affymetrix GeneChip 100 K Set. Case-control studies were performed with 311 women (151 with coronary spasm; 160 controls) using the 10 lowest permutation P value SNPs from the initial SNP analysis. Finally, we discovered SNP rs10498345, a genetic marker for coronary spasm in Japanese women (Odds ratio=0.43, P=9.48x10(-7)). Haplotype analysis showed that haplotype H2, the only haplotype containing the protective A allele at SNP rs10498345, was most strongly associated with coronary spasm (permutation P value <1x10(-4)). SNP rs10498345 was strongly associated with the vasoconstrictor response to acetylcholine. Northern blot analysis revealed a novel 4.7 kb RNA transcript, which lacked poly (A), nearby SNP rs10498345., Conclusions: SNP rs10498345 was strongly associated with coronary spasm in Japanese women utilizing genome-wide SNP analysis.
- Published
- 2007
- Full Text
- View/download PDF
25. The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm.
- Author
-
Nishijima T, Nakayama M, Yoshimura M, Abe K, Yamamuro M, Suzuki S, Shono M, Sugiyama S, Saito Y, Miyamoto Y, Nakao K, Yasue H, and Ogawa H
- Subjects
- Adult, Aged, Calcium Channel Blockers administration & dosage, Calcium Channel Blockers therapeutic use, Cause of Death, Coronary Artery Disease enzymology, Coronary Artery Disease genetics, Female, Follow-Up Studies, Genotype, Humans, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Patient Readmission, Prognosis, Recurrence, Risk Factors, Coronary Vasospasm enzymology, Coronary Vasospasm genetics, Cytosine, Genetic Predisposition to Disease genetics, Nitric Oxide Synthase Type III genetics, Polymorphism, Single Nucleotide genetics, Thymine
- Abstract
Objective: We previously found a -786T/C polymorphism in the 5'-flanking region of the endothelial nitric oxide synthase (eNOS) gene and reported that this polymorphism is strongly associated with coronary spasm. In this study, we examined whether the polymorphism is a prognostic marker in coronary spasm patients., Methods and Results: We examined the clinical courses of 201 consecutive patients with coronary spasm who were admitted to our institution: 146 patients with the -786T/T genotype; 50 patients with the -786C/T genotype; and five patients with the -786C/C genotype. The mean follow-up period was 76+/-60 months. All the patients took calcium channel blockers and/or nitrate during the follow-up period. In this study, no patients died due to a cardiac event. About 25 patients were readmitted owing to cardiovascular disease. Out of these 25 patients, 23 patients were readmitted owing to a reattack of coronary spasm. The -786C allele was significantly associated with readmission due to coronary spasm (P=0.0072, odds ratio: 3.37 in the dominant effect). Kaplan-Meier analysis revealed that the occurrence of readmission was significantly higher in the patients with the -786C allele than in the patients without the -786C allele (P=0.0079). Further, multiple logistic regression analysis revealed that the -786T/C polymorphism was an independent predictor for readmission due to reattack of coronary spasm (P=0.006; relative risk=3.590)., Conclusions: The eNOS -786C allele is an independent risk factor for readmission due to a recurrent attack of coronary spasm in patients with coronary spasm, even if the patients have taken calcium channel blockers and/or nitrate.
- Published
- 2007
- Full Text
- View/download PDF
26. Coronary spasm is associated with chronic low-grade inflammation.
- Author
-
Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, and Yasue H
- Subjects
- Acetylcholine, Aged, Biomarkers blood, Case-Control Studies, Chest Pain drug therapy, Chronic Disease, Coronary Vasospasm chemically induced, Female, Humans, Inflammation blood, Male, Middle Aged, Multivariate Analysis, Nitroglycerin therapeutic use, Risk Factors, Sensitivity and Specificity, Vasodilator Agents therapeutic use, C-Reactive Protein metabolism, Coronary Vasospasm blood, Coronary Vasospasm etiology, Inflammation complications
- Abstract
Background: Coronary spasm plays an important role in the pathogenesis of ischemic heart disease and it may be associated with low-grade inflammation., Methods and Results: Intracoronary injection of acetylcholine was done in 199 patients (99 men, 100 women, mean age, 64.5+/-11.0 years) with chest pain and normal coronary angiograms. According to the results of the provocation test, the study subjects were divided into 2 groups: the spasm group of 112 patients and the non-spasm group of 87 patients. Clinical data including high-sensitivity C-reactive protein (hs-CRP) and other coronary risk factors were compared between the 2 groups. Serum levels of hs-CRP were significantly higher in the spasm group than in the non-spasm group (median: 1.2 mg/L vs 0.5 mg/L, p<0.005). Multivariate analysis showed that hs-CRP and smoking history were independently associated with coronary spasm with an odds ratio of 2.28 (p=0.027) and 2.25 (p=0.037), respectively, with a hs-CRP value of > or = 2 mg/L as cutoff point., Conclusions: Minor elevations of the serum hs-CRP level are significantly associated with coronary spasm, suggesting that chronic low-grade inflammation may be involved in the pathogenesis of coronary spasm.
- Published
- 2007
- Full Text
- View/download PDF
27. A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine.
- Author
-
Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, Suzuki S, Nishijima T, Miyamoto Y, Saito Y, Nakao K, Yasue H, and Ogawa H
- Subjects
- Acetylcholine administration & dosage, Aged, Coronary Vasospasm blood, Female, Humans, Male, Middle Aged, Nitrates blood, Nitrites blood, Vasodilator Agents administration & dosage, Acetylcholine pharmacology, Coronary Vasospasm genetics, Nitric Oxide Synthase Type III genetics, Polymorphism, Genetic, Vasodilator Agents pharmacology
- Abstract
We identified a -786T>C polymorphism in the eNOS gene, and this polymorphism was strongly associated with coronary spasm. The present study aimed to elucidate whether the -786T>C polymorphism or acetylcholine (ACh)-induced coronary spasm affects serum nitrite/nitrate (NOx) levels. The study population comprised three groups: (i) 26 patients without coronary spasm in the left anterior descending coronary artery (LAD) with the T/T genotype (group A); (ii) 20 patients with coronary spasm in the LAD with the T/T genotype (group B); and (iii) 16 patients with coronary spasm in the LAD with the C/T genotype (group C). Paired blood samples were obtained from the coronary sinus (CS) and the aortic tract (Ao) before and after an intracoronary injection of ACh. Serum NOx and plasma lactate levels were measured. The delta NOx level was calculated as the serum concentration of NOx in the CS minus that in the Ao. We compared lactate extraction ratios (LERs) and delta NOx levels between the three groups. The LERs after the provocation test in groups A, B and C were 18.9+/-2.4%, -0.5+/-3.9% and -13.5+/-4.2%, respectively. The LER in group C was significantly lower than in group B. The delta NOx levels after the provocation test in groups A, B and C were 11.5+/-1.7 micromol/l, 10.4+/-3.5 micromol/l and -2.1+/-4.8 micromol/l, respectively. The delta NOx levels in group C were significantly lower (P<0.05). Although the NOx level was significantly increased after the provocation test in group A (P<0.05), the NOx level was significantly decreased after the provocation test in group C (P=0.001). In group B, the provocation test did not significantly change the delta NOx level. In conclusion, the -786T>C polymorphism reduces the NOx level from the heart due to an intracoronary injection of ACh, and thereby predisposes the patients to severe coronary spasm.
- Published
- 2006
- Full Text
- View/download PDF
28. Increased plasma levels of thioredoxin in patients with coronary spastic angina.
- Author
-
Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Hokamaki J, Hirai N, Sugiyama S, Yoshimura M, Yasue H, Nakamura H, Yodoi J, and Ogawa H
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Logistic Models, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Syndrome, Chest Pain blood, Coronary Vasospasm blood, Coronary Vasospasm diagnosis, Thioredoxins blood
- Abstract
To determine whether plasma levels of thioredoxin are associated with coronary spasm, we measured the plasma levels of thioredoxin in 170 patients who had <25% organic stenosis in coronary arteriography. According to the results of cardiac catheterization, we divided the patients into two groups: a coronary spastic angina group (n=84) and a chest pain syndrome group (n=86). The plasma levels of thioredoxin were significantly higher in the coronary spastic angina group than in the chest pain syndrome group (40.7 +/- 4.1 versus 18.2 +/- 1.1 ng/ml, p<0.0001). Furthermore, the increased plasma levels of thioredoxin were associated with high disease activity indicated by the frequency of angina attacks (p=0.0004). In multiple logistic regression analysis, the higher levels of thioredoxin [relative risk 14.8, 95% confidence interval (5.13-42.9), p<0.0001] and current smoking [relative risk 3.39, 95% confidence interval (1.31-8.75), p=0.012] were significant and independent variables associated with coronary spasm. We demonstrated that the plasma levels of thioredoxin were increased in the coronary spastic angina group, and increased levels of thioredoxin were associated with high disease activity. The plasma levels of thioredoxin and current smoking were risk factors for coronary spastic angina, and they were independent from other traditional risk factors.
- Published
- 2004
- Full Text
- View/download PDF
29. Synergistic interaction of T-786-->C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm.
- Author
-
Nakayama M, Yoshimura M, Sakamoto T, Shimasaki Y, Nakamura S, Ito T, Abe K, Yamamuro M, Miyamoto Y, Saito Y, Nakao K, Yasue H, and Ogawa H
- Subjects
- Acetylcholine pharmacology, Aged, Asian People, Base Sequence genetics, Female, Humans, Isosorbide Dinitrate pharmacology, Logistic Models, Male, Middle Aged, Retrospective Studies, Risk Factors, Vasodilation drug effects, Vasodilator Agents pharmacology, Coronary Vasospasm genetics, Nitric Oxide Synthase genetics, Polymorphism, Single Nucleotide, Smoking adverse effects
- Abstract
Objective: We previously reported that a T-786-->C polymorphism in the 5'-flanking region of the endothelial nitric oxide synthase gene and smoking were independently associated with coronary spasm; however, the interaction between this polymorphism and smoking remains to be elucidated., Methods: We analyzed 209 men and 238 women who were admitted consecutively at our institution; all subjects received an intracoronary injection of acetylcholine (ACh) while undergoing coronary angiography for evaluation of chest pain: all subjects had no significant coronary stenosis. We divided these subjects into four groups: non-smokers with T/T genotype (Control Group A); non-smokers with C/T or C/C genotype (Group B); smokers with T/T genotype (Group C); and smokers with C/T or C/C genotype (Group D). We further examined quantitative coronary angiographies of the left anterior descending coronary artery in a subset of 54 consecutive men and 53 consecutive women., Results: The frequencies of coronary spasm in Group B (male: 61%, female: 78%), Group C (62%, 59%) and Group D (91%, 92%) were significantly higher than in Group A (30%, 38%). In the males, ACh-induced vasoconstriction was greatest in Group D, and the change was weakest in Group A. In the females, ACh-induced vasoconstrictions were significantly greater in Groups B, C and D than in Group A. The T-786-->C polymorphism and smoking combine to increase the risk of coronary spasm., (Copyright 2003 Lippincott Williams & Wilkins)
- Published
- 2003
- Full Text
- View/download PDF
30. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina.
- Author
-
Hirai N, Kawano H, Yasue H, Shimomura H, Miyamoto S, Soejima H, Kajiwara I, Sakamoto T, Yoshimura M, Nakamura H, Yodoi J, and Ogawa H
- Subjects
- Administration, Cutaneous, Aged, Angina Pectoris etiology, Biomarkers blood, Biphenyl Compounds, Brachial Artery diagnostic imaging, Brachial Artery drug effects, Coronary Vasospasm complications, Dose-Response Relationship, Drug, Drug Tolerance, Female, Headache etiology, Hemodynamics drug effects, Humans, Male, Middle Aged, Nitrates adverse effects, Nitroglycerin administration & dosage, Nitroglycerin adverse effects, Receptor, Angiotensin, Type 1, Thioredoxins blood, Treatment Outcome, Ultrasonography, Vascular Patency drug effects, Angina Pectoris drug therapy, Angiotensin Receptor Antagonists, Benzimidazoles therapeutic use, Coronary Vasospasm drug therapy, Nitrates therapeutic use, Oxidative Stress drug effects, Tetrazoles therapeutic use
- Abstract
Background: Nitrates are widely used to treat coronary artery disease, but their therapeutic value is compromised by the rapid development of tolerance. Recently, the renin-angiotensin system has been suggested to play an important role in the development of nitrate tolerance., Methods and Results: Sixty-four patients with coronary spastic angina were investigated to clarify the effect of angiotensin II type 1 receptor blocker (ARB) therapy on nitrate tolerance. Transdermal nitroglycerin (10 mg/d) and an ARB (candesartan, 8 mg/d) were administered to 21 patients (GTN+ARB group) for 3 days, whereas transdermal nitroglycerin and placebo were administered to 19 patients (GTN group). Another 18 patients were treated with placebo skin patches and placebo tablets for 3 days (control group). The brachial artery response to incremental doses of intravenous nitroglycerin (0.01, 0.1, and 1.0 micro;g/kg) was measured by ultrasound before and after transdermal nitroglycerin therapy. Before treatment, the arterial diameter was increased by nitroglycerin injection in each group. After treatment, the increase of arterial diameter was significantly suppressed in the GTN group but not in the control or GTN+ARB groups. The plasma level of thioredoxin (a marker of oxidative stress) was increased in the GTN group after treatment (P<0.01) but not in the control or GTN+ARB groups., Conclusions: An ARB suppressed the development of nitrate tolerance during transdermal nitroglycerin therapy. These results suggest that increased oxidative stress induced by activation of angiotensin II may play an important role in the development of nitrate tolerance.
- Published
- 2003
- Full Text
- View/download PDF
31. [Pathogenesis of coronary spasm].
- Author
-
Yasue H
- Subjects
- Humans, Coronary Vasospasm etiology
- Published
- 2003
32. [History of cardiology in the last 100 years: Japanese contribution to studies on coronary vasospasm].
- Author
-
Yasue H
- Subjects
- Acetylcholine physiology, Angina Pectoris, Variant drug therapy, Angina Pectoris, Variant etiology, Angina Pectoris, Variant history, Calcium Channel Blockers therapeutic use, Cardiology history, Coronary Vasospasm complications, History, 20th Century, Japan, Nitroglycerin therapeutic use, Coronary Vasospasm history
- Published
- 2002
33. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
- Author
-
Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Kawano H, and Ogawa H
- Subjects
- Adult, Aged, Amino Acid Substitution, Aryldialkylphosphatase, Cholesterol blood, Coronary Vasospasm blood, Coronary Vasospasm enzymology, Diabetes Complications, Female, Genotype, Humans, Hypertension complications, Male, Middle Aged, Oxidative Stress, Reference Values, Smoking, Thiobarbituric Acid Reactive Substances analysis, Arginine, Coronary Vasospasm genetics, Esterases genetics, Glutamine, Polymorphism, Restriction Fragment Length, Polymorphism, Single Nucleotide
- Abstract
We recently reported that oxidative stress is involved in the pathogenesis of coronary spasm. We hypothesized that oxidative-stress-related genetic factors and certain polymorphisms in the paraoxonase gene (PON1) and platelet-activating factor acetylhydrolase (PAF-AH) might influence the pathogenesis of coronary spasm. We therefore examined the possible association between the PON1 Q192R or PAF-AH V279F polymorphisms and coronary spasm in 214 patients with coronary spasm and 212 control subjects. Genotypes were determined by polymerase chain reaction/restriction fragment length polymorphism analysis. The incidence of the PON1-192R allele was significantly higher in the coronary spasm group than in the control group (65% vs 53%; P=0.0005). The PAF-AH-279F allele was not associated with coronary spasm (15% vs. 16%; P=0.8781). Multiple logistic regression analysis with forward stepwise selection involving the PON1-192R allele and the environmental risk factors revealed that the most predictive independent risk factor for coronary spasm was the PON1-192R allele (significance=0.0016, OR=2.52), followed by cigarette smoking (significance=0.0007, OR=2.01). We also measured plasma levels of TBARS (thiobarbituric acid-reactive substances) as a marker of oxidative stress. TBARS levels were higher in R/R types than in Q/Q types (2.115+/-0.086 nmol/ml [ n=25] vs 1.676+/-0.102 nmol/ml [ n=11], P<0.01). Thus, there is a significant association between the PON1-192R allele and coronary spasm; the PON1-192R allele may play an important role in the genesis of coronary spasm, probably by attenuating the suppression of oxidative stress.
- Published
- 2002
- Full Text
- View/download PDF
34. Enhanced platelet aggregation in the coronary circulation after coronary spasm.
- Author
-
Miyamoto S, Ogawa H, Soejima H, Takazoe K, Kajiwara I, Shimomura H, Sakamoto T, Yoshimura M, Kugiyama K, Yasue H, and Ozaki Y
- Subjects
- Acetylcholine, Adult, Aged, Aorta, Blood Specimen Collection, Chest Pain blood, Cohort Studies, Coronary Angiography, Coronary Circulation, Coronary Vasospasm chemically induced, Coronary Vasospasm diagnostic imaging, Female, Humans, Lactic Acid blood, Lasers, Male, Middle Aged, Scattering, Radiation, Coronary Vasospasm blood, Platelet Aggregation
- Abstract
A recently developed platelet aggregometer using a laser light scattering method is capable of monitoring the increase in size of small-sized platelet aggregates (diameter 9-25 microm), which cannot be detected with the conventional methods. Whether coronary spasm can cause platelet aggregation in the coronary circulation is unknown. We investigated platelet aggregation, especially small-sized platelet aggregates, simultaneously in the coronary sinus and the aortic root in 18 patients with coronary spastic angina before and after a left coronary artery spasm induced by intracoronary injection of acetylcholine, and in 15 patients with stable exertional angina before and after acute myocardial ischemia induced by rapid right atrial pacing. Platelet aggregation in 12 patients with chest pain syndrome was also examined before and after coronary spasms provoked by acetylcholine. The number of small-sized platelet aggregates increased significantly in the coronary sinus [2.0+/-0.6 x 104 to 4.1+/-1.0 x 104 (V), P<.01] and in the aortic root [1.7+/-0.6 x 104 to 3.2+/-0.6 x 104 (V), P<.05], and the coronary sinus-arterial difference in the number of small-sized platelet aggregates [2.3+/-1.9 x 103 to 1.1+/-0.4 x 104 (V), P<.01] increased significantly after attacks in the coronary spastic angina group, but remained the same in the stable exertional angina group after attacks and in the chest pain syndrome group after the administration of acetylcholine. Therefore, we can conclude that acute myocardial ischemia induced by coronary spasm causes platelet aggregation in the coronary circulation.
- Published
- 2001
- Full Text
- View/download PDF
35. Nitric oxide-mediated vasodilatation is decreased in forearm resistance vessels in patients with coronary spastic angina.
- Author
-
Moriyama Y, Tsunoda R, Harada M, Miyao Y, Yoshimura M, Kugiyama K, Ogawa H, and Yasue H
- Subjects
- Acetylcholine pharmacology, Adult, Aged, Enzyme Inhibitors pharmacology, Female, Forearm blood supply, Humans, Male, Middle Aged, Nitric Oxide Synthase antagonists & inhibitors, Regional Blood Flow drug effects, Vasodilation drug effects, Vasodilation physiology, Vasodilator Agents pharmacology, omega-N-Methylarginine pharmacology, Coronary Vasospasm physiopathology, Nitric Oxide physiology, Regional Blood Flow physiology
- Abstract
It has been reported that coronary endothelial dysfunction is associated with the pathogenesis of coronary spasm, and that endothelial nitric oxide (NO) mediated vasodilatation was decreased in coronary epicardial arteries in patients with coronary spastic angina (CSA). However, there are few reports about the endothelial function in peripheral resistance vessels of patients with CSA, so the present study investigated the role of NO in forearm resistance vessels in such patients. The responses of forearm blood flow to acetylcholine (ACh; 8-24 microg/min) and sodium nitroprusside (SNP; 0.4-1.2 microg/ml) infusions was examined using plethysmography, and subsequently the responses to ACh after an infusion of N(G)-monomethyl-L-arginine (L-NMMA; 4 micromol/min, for 5 min) in 17 patients with CSA and 17 age- and sex- matched controls. The vasodilator responses to ACh and SNP were comparable between the 2 groups (p=NS). L-NMMA significantly suppressed the vasodilator responses to ACh in controls (p<0.05), but there was no significant difference in the responses to ACh before and after infusion of L-NMMA in patients with CSA (p=NS). These results indicate that endothelial NO-mediated vasodilatation is decreased in the forearm resistance vessels of patients with CSA.
- Published
- 2001
- Full Text
- View/download PDF
36. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-->C and missense Glu298Asp variants.
- Author
-
Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, and Nakao K
- Subjects
- Adult, Aged, Alleles, DNA analysis, Female, Genetic Markers, Genotype, Humans, Linkage Disequilibrium, Logistic Models, Male, Middle Aged, Nitric Oxide Synthase Type III, Polymerase Chain Reaction, Risk Factors, Smoking, Coronary Vasospasm genetics, Genetic Predisposition to Disease, Mutation, Missense, Nitric Oxide Synthase genetics, Polymorphism, Single Nucleotide genetics
- Abstract
Background: We recently identified two endothelial nitric oxide synthase (eNOS) gene polymorphisms, Glu298Asp and T-786-->C, which are independently associated with coronary spasm. eNOS gene intron 4b/a polymorphism is also reported to be involved in smoking-dependent coronary artery disease. The genetic linkage among these polymorphisms remains unknown. Also, it is unclear which variant is most responsible for coronary spasm. In the present study, we first examined the genetic linkage among these three variants. Next, we studied the risk factors of coronary spasm by using all significant genetic and conventional risk factors in a large-scale study., Methods: The genotype and allele frequencies for the T-786-->C, intron 4b/a, and Glu298Asp variants were assessed in 423 randomly selected DNA samples to examine their genetic linkages. The relative capacities of all risk factors to predict coronary spasm were then analyzed using multiple logistic regression in 201 patients with coronary spasm and 345 volunteers., Results: Comparison of allele frequencies revealed that the eNOS intron 4a allele was significantly linked to the T-786-->C mutation (P < 0.00001), whereas there was not a linkage between the intron 4a allele and the Glu298Asp variant (P = 0.1437) or between the Glu298Asp variant and the T-786-->C mutation (P = 0.1996). Multiple logistic regression revealed that the most predictive independent risk factor for coronary spasm was the T-786-->C mutation (P < 0.001), followed by cigarette smoking (P < 0.001), hypertension (P = 0.004), and the Glu298Asp variant (P = 0.028)., Conclusions: We found that the T-786-->C mutation and the intron 4a allele are in linkage disequilibrium. We previously showed that the T-786-->C mutation reduced eNOS gene promoter activity. In that context, our results strongly suggest that the T-786-->C mutation underlies the functional characteristics of the intron 4a allele. Further, multiple logistic regression analysis revealed that the T-786-->C mutation is the most predictive risk factor for coronary spasm, followed by cigarette smoking. Given that those effects are potentially additive, patients carrying the eNOS gene variants should be strongly cautioned against smoking.
- Published
- 2000
37. Increase in plasma levels of secretory type II phospholipase A(2) in patients with coronary spastic angina.
- Author
-
Kugiyama K, Ota Y, Kawano H, Soejima H, Ogawa H, Sugiyama S, Doi H, and Yasue H
- Subjects
- Acetylcholine, Adult, Aged, Analysis of Variance, Angina Pectoris diagnostic imaging, Case-Control Studies, Coronary Angiography, Coronary Vasospasm diagnostic imaging, Female, Humans, Male, Risk Factors, Vasodilator Agents, Angina Pectoris enzymology, Coronary Vasospasm enzymology, Phospholipases A blood
- Abstract
Objective: Plasma levels of sPLA(2) were increased in various chronic inflammatory diseases including coronary artery disease. Lipid products mediated through PLA(2) have been shown to induce impairment of endothelium-dependent dilation, contraction of smooth muscle and proliferation of smooth muscle cells, all of which might lead to coronary spasm. Thus, this study investigated whether plasma levels of secretory non-pancreatic type II phospholipase A(2) (sPLA(2)) may be increased in patients with coronary spastic angina, considering the possible link of sPLA(2) with pathogenesis of coronary artery spasm., Methods: Plasma levels of sPLA(2) in peripheral circulation, in coronary sinus and in aortic root were measured in 57 patients with coronary spastic angina, 46 patients with stable effort angina and 53 control patients by radioimmunoassay., Results: The peripheral plasma levels of sPLA(2) were increased in patients with coronary spastic angina compared with control patients. In multivariate statistical analysis, the increase in sPLA(2) levels was a significant risk for the presence of coronary spasm independent of other risk factors including C-reactive protein levels. The coronary sinus-arterial difference of plasma sPLA(2) levels, reflecting sPLA(2) released into the coronary circulation, was increased during coronary spasm induced by the intracoronary infusion of acetylcholine in patients with coronary spastic angina, but it remained unchanged both during the acetylcholine infusion and during myocardial ischemia provoked by rapid atrial pacing in patients with stable effort angina and in control patients., Conclusion: The increase in peripheral plasma levels of sPLA(2) is a significant risk factor for the presence of coronary spasm and it may possibly reflect inflammatory activity in spasm coronary arteries.
- Published
- 2000
- Full Text
- View/download PDF
38. Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm.
- Author
-
Ogawa H, Sakamoto T, Nishiyama K, Soejima H, Kaikita K, Takazoe K, Miyamoto S, Kugiyama K, Yoshimura M, and Yasue H
- Subjects
- Aged, Coronary Circulation, Female, Humans, Male, Middle Aged, Coronary Disease blood, Coronary Vasospasm blood, Intercellular Adhesion Molecule-1 blood
- Abstract
The cell surface expression of intercellular adhesion molecule-1 (ICAM-1) is upregulated following activation during inflammatory responses, mediating both cell migration and activation. The involvement of inflammation in unstable angina is suggested by the presence of activated circulating leukocytes. To examine whether plasma soluble ICAM-1 (sICAM-1) levels increase in the coronary circulation of patients with coronary organic stenosis and coronary spasm, plasma sICAM-1 levels were measured in the coronary sinus (CS) and the aortic root (Ao) simultaneously in 10 patients with 90% or more coronary narrowing and coronary spasm (coronary spastic angina (CSA) with organic stenosis), in 11 patients with coronary spasm and no significant coronary narrowing (CSA without organic stenosis), in 16 patients with stable exertional angina, and in 13 control subjects. The plasma sICAM-1 levels (ng/ml) in the CS increased in CSA with organic stenosis (230+/-26) as compared with CSA without organic stenosis (158+/-14), stable exertional angina (130+/-9) and control subjects (121+/-10) (p<0.01). The levels in the Ao also increased in CSA with organic stenosis (208+/-24) as compared with CSA without organic stenosis (149+/-13), stable exertional angina (130+/-11) and control subjects (121+/-10) (p<0.01). Furthermore, the plasma sICAM-1 levels were higher in the CS than in the Ao only in CSA with organic stenosis. These results suggest that activation of leukocytes occurs through the induction of ICAM-1 in the coronary circulation in the patients with CSA with organic stenosis.
- Published
- 2000
- Full Text
- View/download PDF
39. Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography.
- Author
-
Kawano H, Fujii H, Motoyama T, Kugiyama K, Ogawa H, and Yasue H
- Subjects
- Angina Pectoris physiopathology, Coronary Angiography, Drug Monitoring, Electrocardiography, Female, Hemodynamics, Humans, Male, Middle Aged, Prospective Studies, Sensitivity and Specificity, Adrenergic beta-Agonists adverse effects, Angina Pectoris diagnostic imaging, Cardiotonic Agents adverse effects, Coronary Vasospasm chemically induced, Dobutamine adverse effects, Echocardiography methods, Exercise Test methods, Myocardial Ischemia chemically induced
- Abstract
Dobutamine stress echocardiography (DSE) is a useful and safe provocation test for myocardial ischemia. Until now, the test has been focused only on the organic lesion in the coronary artery, and positive DSE has indicated the presence of significant fixed coronary artery stenosis. The aim of the present study is to examine whether myocardial ischemia due to coronary spasm is induced by dobutamine. We performed DSE on 51 patients with coronary spastic angina but without significant fixed coronary artery stenosis. All patients had anginal attacks at rest with ST elevation on the electrocardiogram (variant angina). Coronary spasm was induced by intracoronary injection of acetylcholine, and no fixed coronary artery stenosis was documented on angiograms in all patients. DSE was performed with intravenous dobutamine infusion with an incremental doses of 5, 10, 20, 30, and 40 microg/kg/min every 5 minutes. Of the 51 patients, 7 patients showed asynergy with ST elevation. All 7 patients (13.7%) had chest pain during asynergy, and both chest pain and electrocardiographic changes were preceded by asynergy. These findings indicate that dobutamine can provoke coronary spasm in some patients with coronary spastic angina. When DSE is performed to evaluate coronary artery disease, not only fixed coronary stenosis, but also coronary spasm should be considered as a genesis of asynergy.
- Published
- 2000
- Full Text
- View/download PDF
40. Difference in fibrinolytic activity between multivessel coronary spasm and one-vessel coronary spasm.
- Author
-
Ogawa H, Suefuji H, Takazoe K, Soejima H, Sakamoto T, Miyamoto S, Kaikita K, Yoshimura M, Kugiyama K, and Yasue H
- Subjects
- Angina Pectoris etiology, Cardiac Catheterization, Case-Control Studies, Coronary Angiography, Coronary Vasospasm complications, Coronary Vasospasm diagnosis, Female, Humans, Male, Middle Aged, Myocardial Infarction etiology, Predictive Value of Tests, Prognosis, Recurrence, Coronary Vasospasm blood, Coronary Vasospasm classification, Fibrinolysis, Plasminogen Inactivators blood, Severity of Illness Index, Tissue Plasminogen Activator blood
- Abstract
Plasminogen activator inhibitor activity was higher in 18 patients with multivessel spasm than in 20 patients with 1-vessel spasm and in 22 control patients. Tissue plasminogen activator antigen was also higher in patients with multivessel spasm than in those with 1-vessel spasm and control patients. The increased plasminogen activator inhibitor activity in patients with multivessel spasm indicates that the fibrinolytic system is more impaired in such patients than in those with 1-vessel coronary spasm; this may be related to the higher incidence of refractory angina during hospitalization and cardiac events during the follow-up period.
- Published
- 2000
- Full Text
- View/download PDF
41. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm.
- Author
-
Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, and Nakao K
- Subjects
- Adult, Aged, Alleles, Base Sequence genetics, Female, Gene Frequency, Humans, Male, Middle Aged, Nitric Oxide Synthase Type III, Promoter Regions, Genetic genetics, Reference Values, Regression Analysis, Coronary Vasospasm genetics, Mutation genetics, Nitric Oxide Synthase genetics
- Abstract
Background: Coronary spasm plays an important role in the pathogenesis of ischemic heart diseases in general. However, the precise mechanism(s) responsible for coronary spasm remains to be elucidated, and we examined the molecular genetics of coronary spasm., Methods and Results: We searched for the possible mutations in the endothelial nitric oxide synthase (eNOS) gene in patients with coronary spasm. In this study, we demonstrate the existence of 3 linked mutations in the 5'-flanking region of the eNOS gene (T-786-->C, A-922-->G, and T-1468-->A). The incidence of the mutations was significantly greater in patients with coronary spasm than in the control group (P<0.0001). Multiple logistic regression analysis with forward stepwise selection using the environmental risk factors and the eNOS gene variant revealed that the most predictive independent risk factor for coronary spasm was the mutant allele (P<0.0001). As assessed by luciferase reporter gene assays, the T-786-->C mutation resulted in a significant reduction in eNOS gene promoter activity (P<0.05), whereas neither the A-922-->G nor the T-1468-->A mutation had any affect., Conclusions: Taken together, these findings strongly suggest that the T-786-->C mutation in the eNOS gene reduces the endothelial NO synthesis and predisposes the patients with the mutation to coronary spasm.
- Published
- 1999
- Full Text
- View/download PDF
42. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina.
- Author
-
Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, and Yasue H
- Subjects
- Adult, Aged, Angina Pectoris, Variant etiology, Arteries physiopathology, Brachial Artery physiopathology, Coronary Vessels physiopathology, Female, Hemodynamics physiology, Humans, Male, Middle Aged, Regional Blood Flow physiology, Smoking, Thiobarbituric Acid Reactive Substances analysis, Vasodilation physiology, Vitamin E blood, Angina Pectoris, Variant drug therapy, Angina Pectoris, Variant physiopathology, Coronary Vasospasm complications, Endothelium, Vascular physiopathology, Vasodilation drug effects, Vitamin E therapeutic use
- Abstract
Objectives: We examined the effects of oral administration of vitamin E, an antioxidant, on endothelium-dependent vasodilation in patients with coronary spastic angina., Background: We have recently reported that endothelium-dependent vasodilation is impaired in patients with coronary spastic angina (CSA). Furthermore, it is known that oxidative stress may play an important role in the impairment of endothelium-dependent vasodilation in cardiovascular diseases., Methods: With the ultrasound technique, flow-dependent vasodilation of the brachial arteries during reactive hyperemia was examined before and after treatment for a month with either oral administration of vitamin E (alpha-tocopherol acetate, 300 mg/day) or placebo, which is randomly assigned, in patients with CSA (n=60)., Results: Before treatment, patients with CSA had impaired flow-dependent vasodilation, lower plasma levels of alpha-tocopherol and higher plasma levels of thiobarbituric acid reactive substances (TBARS), as compared with age- and sex-matched control subjects (n=60) (flow-dependent vasodilation: 3.1+/-1.8 vs. 7.1+/-2.5%, p < 0.001; alpha-tocopherol levels: 8.9+/-1.8 vs. 10.8+/-1.8 microg/ml, p < 0.001). In patients with CSA, treatment with vitamin E restored flow-dependent vasodilation (3.1+/-1.7 vs. 8.3+/-2.0%, p < 0.001), and this improvement was associated with the decreases in plasma TBARS levels and anginal attacks., Conclusions: The results indicate that vitamin E treatment improved endothelium-dependent vasodilation and decreased plasma TBARS levels in patients with CSA. Thus, increased oxidative stress may contribute to endothelial dysfunction and anginal attacks in patients with CSA.
- Published
- 1998
- Full Text
- View/download PDF
43. [Pathophysiology of coronary spasm].
- Author
-
Kugiyama K and Yasue H
- Subjects
- Acetylcholine pharmacology, Animals, Coronary Vasospasm physiopathology, Endothelium, Vascular metabolism, Enzyme Inhibitors pharmacology, Humans, Nitric Oxide metabolism, Nitric Oxide Synthase antagonists & inhibitors, Nitroglycerin pharmacology, Oxidative Stress physiology, Vasodilator Agents pharmacology, omega-N-Methylarginine pharmacology, Coronary Vasospasm etiology
- Abstract
There is a deficiency in both basal and stimulated NO release in the spasm arteries of patients with coronary spastic angina. The deficient NO release may lead to the supersensitivity of the artery to the vasodilator effect of nitroglycerin and to the vasoconstrictor effect of acetylcholine in patients with coronary spastic angina. Flow-dependent coronary dilation of proximal LAD was found to be less in spasm arteries than in control arteries. The infusion of L-NMMA in the proximal site of LAD suppressed the flow-dependent dilation in control arteries, while L-NMMA did not have significant effect in spasm arteries. The results indicate that flow-dependent coronary dialtion is impaired in spasm arteries partly due to deficiency in endothelial NO bioactivity, which in turn may possibly contribute to increase in coronary tone during the physiological stress in patients with coronary spastic angina.
- Published
- 1998
44. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina.
- Author
-
Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, Kawano H, Miyao Y, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, and Yasue H
- Subjects
- Acetylcholine, Adult, Aged, Coronary Angiography, Dose-Response Relationship, Drug, Endothelium, Vascular drug effects, Endothelium, Vascular physiopathology, Female, Hemodynamics drug effects, Hemodynamics physiology, Humans, Infusions, Intra-Arterial, Male, Middle Aged, Vascular Resistance drug effects, Vascular Resistance physiology, Vasomotor System drug effects, Vasomotor System physiopathology, Angina Pectoris, Variant physiopathology, Antioxidants pharmacology, Ascorbic Acid pharmacology, Coronary Vasospasm physiopathology, Reactive Oxygen Species metabolism
- Abstract
Objectives: This study sought to examine effect of vitamin C, an antioxidant, on the abnormal vasomotor reactivity in spasm coronary arteries., Background: Oxygen free radicals generated in the arterial walls have been shown to cause endothelial vasomotor dysfunction., Methods: Responses of the epicardial arterial diameters of the left coronary arteries to the intracoronary infusion of acetylcholine (ACh) (10 and 50 microg/min) were measured by quantitative coronary angiography before and during combined intracoronary infusion of vitamin C (10 mg/min) or saline as a placebo in 32 patients with coronary spastic angina and in 34 control subjects., Results: Vitamin C infusion suppressed the constrictor response of the epicardial diameter to ACh in spasm coronary arteries but had no significant effect in the control coronary arteries (percent change in distal diameter in response to 10 microg/min of ACh [constriction (-), dilation (+), mean +/- SEM] before vitamin C: -8.2 +/- 2.9% in spasm arteries, +8.4 +/- 2.9%* in control arteries; during vitamin C: +0.2 +/- 3.8%* in spasm arteries, +7.2 +/- 1.3%* in control arteries [*p < 0.01 vs. spasm arteries before vitamin CI). The coronary sinus-arterial difference in plasma thiobarbituric acid reactive substances during ACh infusion, an indicator of lipid peroxidation in coronary circulation, was higher in patients with coronary spastic angina than in control subjects (p < 0.01) but was suppressed in patients with coronary spastic angina to comparable levels in control subjects by combined infusion of vitamin C. Saline infusion had no effect., Conclusions: The results indicate that vitamin C attenuates vasomotor dysfunction in epicardial coronary arteries in patients with coronary spastic angina. Oxygen free radicals may at least in part play a role in the abnormal coronary vasomotor reactivity in response to ACh in spasm coronary arteries.
- Published
- 1998
- Full Text
- View/download PDF
45. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese.
- Author
-
Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, and Nakao K
- Subjects
- Adult, Aged, Amino Acid Substitution, Aspartic Acid, Coronary Vasospasm enzymology, Exons, Female, Genes, Dominant, Glutamic Acid, Heterozygote, Homozygote, Humans, Japan, Male, Middle Aged, Nitric Oxide Synthase Type III, Polymerase Chain Reaction, Coronary Vasospasm genetics, Genetic Variation, Nitric Oxide Synthase genetics, Point Mutation
- Abstract
Coronary spasm plays an important role in the pathogenesis of not only variant angina but also ischemic heart disease in general. However, the precise mechanism(s) by which coronary spasm occurs remains to be elucidated. Coronary spasm may arise from interactions between environmental and genetic factors. Endothelial-derived nitric oxide (NO) has been implicated in the control of vascular tone. We have recently shown that both basal and acetylcholine (ACh)-induced NO activities are impaired in the coronary arteries of patients with coronary spasm. The purpose of this study has been to elucidate the possible variants that occur in the coding region of the endothelial nitric oxide synthase (eNOS) gene and that may be associated with coronary spasm. After initial screening in the entire 26 coding regions of the eNOS gene, we found a missense Glu298Asp variant in exon 7 in patients with coronary spasm. We subsequently performed a larger scale study involving 113 patients with coronary spasm and 100 control subjects, who were all diagnosed by intracoronary injection of ACh. The analysis revealed a significant difference in the distribution of the variant between the coronary spasm group (21.2%) and control group (9.0%; P=0.014 for dominant effect). Thus, we have found the missense Glu298Asp variant in the eNOS gene by the analysis of its entire 26 coding regions. The variant is significantly associated with coronary spasm.
- Published
- 1998
- Full Text
- View/download PDF
46. Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina.
- Author
-
Misumi K, Ogawa H, Yasue H, Soejima H, Suefuji H, Nishiyama K, Takazoe K, Kugiyama K, Tsuji I, and Kumeda K
- Subjects
- Adult, Aged, Angina Pectoris blood, Angina Pectoris epidemiology, Angina Pectoris physiopathology, Angina, Unstable epidemiology, Angina, Unstable physiopathology, Cardiac Catheterization, Coronary Angiography, Coronary Vasospasm epidemiology, Coronary Vasospasm physiopathology, Female, Humans, Male, Middle Aged, Physical Exertion, Risk Factors, Secretory Rate, Angina, Unstable blood, Circadian Rhythm, Coronary Vasospasm blood, Endothelium, Vascular metabolism, Lipoproteins blood
- Abstract
Tissue factor pathway inhibitor (TFPI) is known to inhibit the initial reaction in the tissue factor-mediated coagulation pathway. We measured plasma free-form TFPI antigen levels and monitored 24-h Holter recordings at 06.00, 14.00 and 22.00 h in 15 patients with coronary spastic angina, 13 patients with stable exertional angina, and 11 control subjects. There was a significant circadian variation in plasma free-form TFPI antigen levels in patients with coronary spastic angina (25.8+/-2.0 ng/ml at 06.00 h, 21.1+/-1.6 ng/ml at 14.00 h, and 20.2+/-1.4 ng/ml at 22.00 h; p<0.01). Furthermore, free-form TFPI antigen levels at 06.00 h were significantly higher in coronary spastic angina patients than in patients with stable exertional angina or control subjects (p<0.01). Free-form TFPI antigen levels increased after the ischemic attacks in coronary spastic angina (p<0.01). This circadian variation correlated with the frequency of attacks, with the peak level occurring between midnight to early morning in patients with coronary spastic angina.
- Published
- 1998
- Full Text
- View/download PDF
47. Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina.
- Author
-
Nishiyama K, Ogawa H, Yasue H, Soejima H, Misumi K, Kugiyama K, Tsuji I, and Kumeda K
- Subjects
- Aged, Angina Pectoris physiopathology, Coronary Circulation, Coronary Vasospasm physiopathology, Endothelium, Vascular metabolism, Endothelium, Vascular physiopathology, Female, Humans, Male, Middle Aged, Angina Pectoris blood, Anticoagulants administration & dosage, Coronary Vasospasm blood, Heparin administration & dosage, Lipoproteins blood
- Abstract
Tissue factor pathway inhibitor (TFPI) is a physiological regulator of the extrinsic coagulation cascade. Coronary spasm can alter endothelial cell properties in the coronary artery with resultant thrombosis. To determine whether coronary spasm affects plasma TFPI level, we measured the heparin-releasable endothelial cell-associated TFPI (heparin-releasable TFPI) (ng/ml) in the coronary sinus and the aortic root before and after coronary spasm induced by an injection of acetylcholine in 18 patients with coronary spastic angina, and before and after myocardial ischemia induced by rapid atrial pacing in 18 patients with stable exertional angina, and in 17 control subjects with normal coronary arteries and no coronary spasm. Heparin-releasable TFPI level in the coronary spastic angina group significantly increased in the coronary sinus (1 22+/-46 to 147+/-63, p<0.001) after the ischemic event but not in the aortic root (113+/-44 to 121+/-58). The level in the coronary sinus and the aortic root remained unchanged after the ischemic event in the stable exertional angina group and after the injection of acetylcholine in the control group. The coronary sinus-arterial difference in the amount of the heparin-releasable TFPI significantly increased after the ischemic event only in the coronary spastic angina group (10+/-18 to 26+/-18, p<0.002). Our result suggested that heparin-releasable TFPI is increased in the coronary circulation after coronary spasm.
- Published
- 1998
- Full Text
- View/download PDF
48. [Physiopathology of sudden death--multivessel coronary artery spasm].
- Author
-
Kugiyama K, Nakao K, and Yasue H
- Subjects
- Coronary Angiography, Coronary Vasospasm diagnosis, Coronary Vasospasm drug therapy, Electrocardiography, Heart diagnostic imaging, Humans, Radionuclide Imaging, Arrhythmias, Cardiac complications, Coronary Vasospasm complications, Death, Sudden, Cardiac etiology
- Published
- 1998
49. Coronary spasm: clinical features and pathogenesis.
- Author
-
Yasue H and Kugiyama K
- Subjects
- Acetylcholine metabolism, Autonomic Nervous System metabolism, Autonomic Nervous System physiopathology, Circadian Rhythm, Coronary Angiography, Coronary Vessels metabolism, Electrocardiography, Humans, Hyperventilation complications, Hyperventilation metabolism, Nitric Oxide metabolism, Risk Factors, Vasoconstriction, Coronary Vasospasm etiology, Coronary Vasospasm pathology, Coronary Vasospasm physiopathology, Coronary Vessels pathology, Endothelium, Vascular metabolism
- Abstract
Coronary artery spasm (coronary spasm) is an abnormal contraction of an epicardial coronary artery resulting in myocardial ischemia and its incidence is relatively high in Japanese as compared with Caucasians. Coronary spasm occurs most often from midnight to early morning when the patient is at rest and it is usually not induced by exercise in the daytime. Coronary spasm can be induced by acetylcholine, an endothelium-dependent vasodilator which causes vasodilatation in the normal coronary artery. Spasm artery is hyperresponsive to the vasodilator effect of nitroglycerin, an nitric oxide (NO) donor and is deficient in NO activity. The major risk factor for coronary spasm is cigarette smoking. Coronary spasm can be a cause of not only variant angina but also ischemic heart disease in general, including unstable angina, acute myocardial infarction and sudden ischemic death.
- Published
- 1997
- Full Text
- View/download PDF
50. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina.
- Author
-
Kugiyama K, Ohgushi M, Motoyama T, Sugiyama S, Ogawa H, Yoshimura M, Inobe Y, Hirashima O, Kawano H, Soejima H, and Yasue H
- Subjects
- Adenosine pharmacology, Adult, Aged, Case-Control Studies, Coronary Angiography, Coronary Vasospasm diagnosis, Echocardiography, Doppler, Electrocardiography, Female, Humans, Male, Middle Aged, Nitric Oxide Synthase antagonists & inhibitors, Vasodilator Agents pharmacology, omega-N-Methylarginine pharmacology, Angina Pectoris, Variant etiology, Coronary Vasospasm complications, Coronary Vasospasm physiopathology, Coronary Vessels drug effects, Nitric Oxide physiology, Vasodilation drug effects
- Abstract
Objectives: This study sought to examine whether flow-dependent dilation is impaired at the site of coronary artery spasm in patients with coronary spastic angina., Background: Physiologic stimuli such as exercise and exposure to cold have been shown to cause an increase in coronary blood flow, leading to flow-dependent dilation of coronary arteries in normal subjects, but cause coronary constriction in patients with coronary spastic angina., Methods: A maximal increase in blood flow was induced selectively in the left anterior descending coronary artery (LAD) by infusion of adenosine through a Doppler flow catheter tip in the midportion of the LAD in 10 patients with coronary spastic angina, all with angiographically demonstrated spasm of the LAD, and in 11 control patients. Coronary artery diameter at the proximal site of the LAD (exposed to increased flow but not to adenosine) was measured by quantitative angiography., Results: Flow-dependent dilation of the proximal LAD was found to be less in spasm arteries than in control arteries. Infusion of NG-monomethyl-L-arginine (L-NMMA) in the proximal LAD suppressed flow-dependent dilation in control arteries but had no significant effect on spasm arteries. The dilator response to nitroglycerin was not impaired in spasm coronary arteries., Conclusions: Our results indicate that flow-dependent coronary dilation is impaired in spasm arteries, partly due to a deficiency in endothelial nitric oxide bioactivity, which in turn may contribute to the increase in coronary tone during physiologic stimuli in patients with coronary spastic angina.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.